Finance

Beta
Lists
GRCE:NASDAQ
Grace Therapeutics, Inc
$2.38
+7.21%
(+0.16) 1D
$2.30
-3.36% (-0.080)
After hours
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GRCE...
Open
$2.22
High
$2.38
Low
$2.21
Mkt. cap
36.83M
Avg. vol.
330.36K
Volume
280.31K
52-wk high
$5.18
52-wk low
$1.79
EPS
-$0.36
Beta
1.13
Shares outstanding
15.47M
No. of employees
6
Open
$2.22
High
$2.38
Low
$2.21
Mkt. cap
36.83M
Avg. vol.
330.36K
Volume
280.31K
52-wk high
$5.18
52-wk low
$1.79
EPS
-$0.36
Beta
1.13
Shares outstanding
15.47M
No. of employees
6
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to GRCE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GRCE in the last 3 months.
Highest
Current $2.38
$8.00 (+236.13%)
Average
$6.00 (+152.10%)
Lowest
$4.00 (+68.07%)
News stories
From sources across the web
About Grace Therapeutics, Inc
CEO-
Employees6
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitegracetx.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
955.00K
568.00K
462.00K
420.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.14M
1.96M
1.99M
2.59M
Operating expense
3.09M
2.53M
2.45M
3.01M
Total operating expenses
3.09M
2.53M
2.45M
3.01M
Operating income
-3.09M
-2.53M
-2.45M
-3.01M
Other non operating income
-487.00K
1.43M
-42.00K
-
EBT including unusual items
-3.36M
-938.00K
-2.32M
-2.88M
EBT excluding unusual items
-3.36M
-938.00K
-2.32M
-2.88M
Income tax expense
-
-
-
-1.70M
Effective tax rate
-
-
-
59.07%
Other operating expenses
-
-
-
-
Net income
-3.36M
-938.00K
-2.32M
-1.18M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
205.00K
172.00K
172.00K
138.00K
Interest expense
-
-
-
-
Net interest expenses
205.00K
172.00K
172.00K
138.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.09M
-2.53M
-2.45M
-3.01M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer